Comparing Two Methylphenidate Treatments for Adult ADHD
Author Information
Author(s): Biederman Joseph, Mick Eric O, Surman Craig, Doyle Robert, Hammerness Paul, Michel Evan, Martin Jessica, Spencer Thomas J
Primary Institution: Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, Boston, MA
Hypothesis
Once daily OROS-MPH would show similar efficacy and tolerability to that of IR-MPH administered three times a day.
Conclusion
Once daily OROS-MPH has similar efficacy and tolerability to that of IR-MPH administered three times daily.
Supporting Evidence
- Both OROS-MPH and IR-MPH showed statistically significant improvement compared to placebo.
- The response rate for both medications was significantly higher than placebo.
- Adverse effects were more common in both active treatment groups compared to placebo.
Takeaway
This study looked at two types of ADHD medication for adults and found that taking one pill a day works just as well as taking three pills a day.
Methodology
Two six-week, randomized, placebo-controlled trials were conducted comparing OROS-MPH and IR-MPH in adults with ADHD.
Potential Biases
Self-reports may not fully capture ADHD symptoms, and adverse effects were assessed through spontaneous reports.
Limitations
The study had stricter ADHD criteria than DSM-IV and relied on self-reports for diagnosis and symptom assessment.
Participant Demographics
Outpatient adults aged 19 to 60 with DSM-IV ADHD.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website